Choline salicylate
As of the edition of 20 October 2026, Choline salicylate is a small molecule: marketed, first approved in 1981 (FR).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1981
- Kind
- Small molecule
- Brand name
- Pansoral
- First approved
- 31 July 1981 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Pierre Fabre
- Registered trials
- 2, 0 stopped early
- Disease areas
- Blood and lymph; Cancer; Heart and blood vessels; Immune system; Mouth and teeth
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| Phase 1 | 1 | 1 | 0 | 0 |
| All trials | 2 |